So I really depend on my medication." Sir Peter Luff, a former defence minister and MP for Mid Worcestershire, explained how ...
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his ...
Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...
StudyFinds on MSN12d
Nanoparticle treatment reverses Parkinson’s disease in miceInnovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...
A new study by researchers at Ireland's Maynooth University, based on patient data gathered by the US-based Michael J. Fox Foundation, found that an overwhelming 84% of patients with Parkinson's ...
In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...
In a significant advancement for Parkinson’s Disease (PD) therapy, researchers have developed a targeted nano formulation ...
Irish Independent on MSN4h
Maynooth University study reveals how poor sleep affects Parkinson’s patientsSleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback